95 related articles for article (PubMed ID: 2156210)
1. Down-regulation of MHC class I antigens is not a general mechanism for the increased tumorigenicity caused by c-myc amplification.
Dahllöf B
Oncogene; 1990 Mar; 5(3):433-5. PubMed ID: 2156210
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
[TBL] [Abstract][Full Text] [Related]
3. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
4. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
Lavialle C; Modjtahedi N; Cassingena R; Brison O
Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
[TBL] [Abstract][Full Text] [Related]
5. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
6. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene amplification and human breast tumor phenotype.
Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
[TBL] [Abstract][Full Text] [Related]
8. MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression.
Cromme FV; Snijders PJ; van den Brule AJ; Kenemans P; Meijer CJ; Walboomers JM
Oncogene; 1993 Nov; 8(11):2969-75. PubMed ID: 8414499
[TBL] [Abstract][Full Text] [Related]
9. The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes.
Kushtai G; Barzilay J; Feldman M; Eisenbach L
Oncogene; 1988 Feb; 2(2):119-27. PubMed ID: 2453011
[TBL] [Abstract][Full Text] [Related]
10. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
[TBL] [Abstract][Full Text] [Related]
11. Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas.
Sturm SA; Strauss PG; Adolph S; Hameister H; Erfle V
Cancer Res; 1990 Jul; 50(13):4146-53. PubMed ID: 2141296
[TBL] [Abstract][Full Text] [Related]
12. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of the N-myc gene in Wilms' tumors.
Nisen PD; Zimmerman KA; Cotter SV; Gilbert F; Alt FW
Cancer Res; 1986 Dec; 46(12 Pt 1):6217-22. PubMed ID: 2430692
[TBL] [Abstract][Full Text] [Related]
14. Molecular mediators and events associated with attenuated MHC class I gene expression.
Zeff RA
Semin Cancer Biol; 1991 Oct; 2(5):287-93. PubMed ID: 1773045
[TBL] [Abstract][Full Text] [Related]
15. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas.
Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M
Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682
[TBL] [Abstract][Full Text] [Related]
16. Alterations in growth properties of human papilloma virus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression of c-myc oncogene.
Crook T; Greenfield I; Howard J; Stanley M
Oncogene; 1990 Apr; 5(4):619-22. PubMed ID: 2158040
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative syndrome associated with c-myc expression driven by a class I gene promoter in transgenic mice.
Morello D; Lavenu A; Bandeira A; Portnoi D; Gaillard J; Babinet C
Oncogene Res; 1989; 4(2):111-25. PubMed ID: 2654814
[TBL] [Abstract][Full Text] [Related]
18. c-myc and c-fos gene regulation during mouse liver regeneration.
Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
[TBL] [Abstract][Full Text] [Related]
19. Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors.
Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Felber M; Sawey MJ
Cancer Res; 1990 May; 50(10):3073-7. PubMed ID: 2185880
[TBL] [Abstract][Full Text] [Related]
20. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
Ibson JM; Rabbitts PH
Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]